HS code: 30
Country | |
Direction | |
Country | |
Period | |
Selection products |
Period | Total |
---|---|
2019 | $1.8 M |
Total: | $1.8 M |
Period | Weight, tons. |
---|---|
2019 | 75.2 |
Total: | 75.2 |
Group product | 2019 | 2019 | Ch. | ∑ (2019-2019) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | --- | --- | --- | --- | 0% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | --- | --- | --- | --- | 0% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | --- | --- | --- | --- | 0% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | $1.8 M | $1.8 M | 0% | $1.8 M | 100% |
06 3005: Wadding, gauze, bandages and similar articles | --- | --- | --- | --- | 0% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | --- | --- | --- | --- | 0% |
Total: | $1.8 M | $1.8 M | $1.8 M |
№ | Country | ∑ (2019-2019) | Ratio |
---|---|---|---|
1 | Serbia | $34.2 M | 14.3% |
2 | Montenegro | $26.5 M | 11.1% |
3 | Spain | $21.9 M | 9.2% |
4 | Germany | $20.2 M | 8.4% |
5 | Kazakhstan | $20 M | 8.4% |
6 | Latvia | $18.7 M | 7.8% |
7 | Ukraine | $14.8 M | 6.2% |
8 | Italy | $9 M | 3.8% |
9 | Hungary | $8.7 M | 3.6% |
10 | Moldova | $8 M | 3.3% |
11 | Belarus | $6.4 M | 2.7% |
12 | India | $5.7 M | 2.4% |
13 | Azerbaijan | $4.9 M | 2.1% |
14 | Kyrgyzstan | $4.7 M | 2% |
15 | Armenia | $4.7 M | 2% |
... | ... | ... | ... |
20 | Georgia | $2.4 M | 1% |
21 | Uzbekistan | $2.3 M | 1% |
22 | Bosnia and Herzegovina | $1.8 M | 0.8% |
23 | United States | $1.2 M | 0.5% |
24 | Finland | $1.1 M | 0.4% |
... | ... | ... | ... |
The total for all countries: | $239 M | 100% |
№ | Region | ∑ (2019-2019) | Ratio |
---|---|---|---|
1 | Moskovskaya oblast | $25.5 M | 49% |
2 | Moskva | $24.6 M | 47.4% |
3 | Nijegorodskaya oblast | $1.8 M | 3.5% |
4 | Belgorodskaya oblast | $14.5 K | 0% |
5 | Sankt-Peterburg | $6.91 K | 0% |
6 | Rostovskaya oblast | $74 | 0% |
By all regions: | $51.9 M | 100% |